Skip to main content
Erschienen in: Abdominal Radiology 9/2021

17.05.2021 | Interventional Radiology

Safety and efficacy of percutaneous transabdominal and transesophageal decompression gastric catheters for palliation of malignant bowel obstruction

verfasst von: Robert J. Litwin, Alda L. Tam, Rahul A. Sheth, Steven M. Yevich, Johanna L. Chan, Amir A. Jazaeri, Josiah K. Halm, Sanjay Gupta, Steven Y. Huang

Erschienen in: Abdominal Radiology | Ausgabe 9/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the safety and primary technical success rate of gastric decompression via percutaneous transabdominal gastrostomy (PTAG) or percutaneous transesophageal gastric (PTEG) catheter placement for management of malignant bowel obstruction (MBO). A secondary purpose was to evaluate the safety and success rate for PTAG catheter placement in patients with both MBO and ascites.

Methods

A single-institution retrospective review of 385 patients who underwent attempted decompression gastric catheter placement from March 2013 to August 2018 was performed. Medical records and imaging studies were reviewed. A subgroup of patients with concomitant MBO and ascites were identified. The primary outcome measures were procedural technical success and procedural complications.

Results

394 decompression gastrostomy catheters were attempted from 2013 to 2018, n = 353 PTAG and n = 41 PTEG. The success rate was 95.5% (n = 337 of 353) for PTAG and 97.6% (n = 40 of 41) for PTEG. There were 63 total complications involving 47 (13.9%) patients following PTAG and 13 total complications involving 9 (22.5%) patients following PTEG, P = 0.16. For the subgroup of patients with MBO and ascites, the success rate was 94.8% (n = 182 of 192 patients), and there were 20 complications involving 17 (12.9%) of 132 patients.

Conclusion

Gastric decompression for patients with MBO via PTAG or PTEG catheter placement is associated with high success rates and low complications.
Literatur
3.
Zurück zum Zitat Miller G, Boman J, Shrier I, Gordon PH (2000) Small-bowel obstruction secondary to malignant disease: an 11-year audit. Can J Surg 43 (5):353–358PubMedPubMedCentral Miller G, Boman J, Shrier I, Gordon PH (2000) Small-bowel obstruction secondary to malignant disease: an 11-year audit. Can J Surg 43 (5):353–358PubMedPubMedCentral
12.
Zurück zum Zitat Campagnutta E, Cannizzaro R (2000) Percutaneous endoscopic gastrostomy (PEG) in palliative treatment of non-operable intestinal obstruction due to gynecologic cancer: a review. Eur J Gynaecol Oncol 21 (4):397–402PubMed Campagnutta E, Cannizzaro R (2000) Percutaneous endoscopic gastrostomy (PEG) in palliative treatment of non-operable intestinal obstruction due to gynecologic cancer: a review. Eur J Gynaecol Oncol 21 (4):397–402PubMed
16.
Zurück zum Zitat Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V, Expert Working Group of the Research Network of the European Association for Palliative C (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84 (5):587–593. https://doi.org/10.1054/bjoc.2001.1680CrossRef Hanks GW, Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Casas JR, Sawe J, Twycross RG, Ventafridda V, Expert Working Group of the Research Network of the European Association for Palliative C (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84 (5):587–593. https://​doi.​org/​10.​1054/​bjoc.​2001.​1680CrossRef
17.
Zurück zum Zitat Tassinari D, Sartori S, Tamburini E, Scarpi E, Tombesi P, Santelmo C, Maltoni M (2009) Transdermal fentanyl as a front-line approach to moderate-severe pain: a meta-analysis of randomized clinical trials. J Palliat Care 25 (3):172–180CrossRefPubMed Tassinari D, Sartori S, Tamburini E, Scarpi E, Tombesi P, Santelmo C, Maltoni M (2009) Transdermal fentanyl as a front-line approach to moderate-severe pain: a meta-analysis of randomized clinical trials. J Palliat Care 25 (3):172–180CrossRefPubMed
20.
Zurück zum Zitat Ventafridda V, Ripamonti C, Caraceni A, Spoldi E, Messina L, De Conno F (1990) The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 76 (4):389–393CrossRefPubMed Ventafridda V, Ripamonti C, Caraceni A, Spoldi E, Messina L, De Conno F (1990) The management of inoperable gastrointestinal obstruction in terminal cancer patients. Tumori 76 (4):389–393CrossRefPubMed
22.
Zurück zum Zitat Aramaki T, Arai Y, Takeuchi Y, Sone M, Sato R, Bekku E, Moriguchi M (2020) A randomized, controlled trial of the efficacy of percutaneous transesophageal gastro-tubing (PTEG) as palliative care for patients with malignant bowel obstruction: the JIVROSG0805 trial. Support Care Cancer 28 (6):2563–2569. https://doi.org/10.1007/s00520-019-05066-8CrossRefPubMed Aramaki T, Arai Y, Takeuchi Y, Sone M, Sato R, Bekku E, Moriguchi M (2020) A randomized, controlled trial of the efficacy of percutaneous transesophageal gastro-tubing (PTEG) as palliative care for patients with malignant bowel obstruction: the JIVROSG0805 trial. Support Care Cancer 28 (6):2563–2569. https://​doi.​org/​10.​1007/​s00520-019-05066-8CrossRefPubMed
Metadaten
Titel
Safety and efficacy of percutaneous transabdominal and transesophageal decompression gastric catheters for palliation of malignant bowel obstruction
verfasst von
Robert J. Litwin
Alda L. Tam
Rahul A. Sheth
Steven M. Yevich
Johanna L. Chan
Amir A. Jazaeri
Josiah K. Halm
Sanjay Gupta
Steven Y. Huang
Publikationsdatum
17.05.2021
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 9/2021
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-021-03115-7

Weitere Artikel der Ausgabe 9/2021

Abdominal Radiology 9/2021 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.